DSC_0030-Edit
Hemex Health and Mylab Discovery Solutions Launch Gazelle™ PathoCatch™ COVID-19 FIA Test
July 06, 2022 08:00 ET | Hemex Health
PORTLAND, Ore. and PUNE, India, July 06, 2022 (GLOBE NEWSWIRE) -- Mylab Discovery Solutions, India’s leading biotechnology company, and Portland, OR-based Hemex Health, a medical diagnostic device...
attralus-logo.png
Positive New Data from Phase 1/2 Trial of AT-01 (Iodine I-124 Evuzamitide) Presented at 2022 Society of Nuclear Medicine & Molecular Imaging Annual Meeting
June 14, 2022 11:45 ET | Attralus, Inc
AT-01 is the first pan-amyloid imaging agent capable of detecting diverse types of systemic amyloidosisAT-01 visualizes and quantifies organ-specific changes in amyloid load over time AT-01 detected...
attralus-logo.png
Attralus to Present New AT-01 Data at 2022 Society of Nuclear Medicine & Molecular Imaging Annual Meeting
June 03, 2022 08:00 ET | Attralus, Inc
Final Phase 1/2 Study Results for AT-01 (Evuzamitide), Attralus's Novel Pan-Amyloid Imaging Agent for the Detection of Systemic Amyloidosis Repeat PET/CT Imaging of a Patient with Systemic Amyloidosis...
ADPT new logo.jpg
Adaptive Biotechnologies Included in Key Abstracts at ASCO 2022 Supporting the Role of the clonoSEQ® Assay as a Standard for MRD Assessment Technology
June 02, 2022 16:10 ET | Adaptive Biotechnologies
SEATTLE, June 02, 2022 (GLOBE NEWSWIRE) -- Data from Adaptive Biotechnologies Corporation (Nasdaq: ADPT), a commercial stage biotechnology company that aims to translate the genetics of the adaptive...
Inserting the Hb variant cartridge into the Gazelle Reader for analysis
Hemex Health announces breakthrough measurement capability for clinicians monitoring sickle cell disease therapy
May 08, 2022 06:00 ET | Hemex Health
PORTLAND, Ore. and MUMBAI, India, May 08, 2022 (GLOBE NEWSWIRE) -- Hemex Health, a Portland, Oregon-based health-tech startup, announced a significant enhancement to their Gazelle™ Hb Variant test,...
Featured Image for Endominance, Inc.
Endominance Launches Exciting New Microbiome, Anxiety, and Cognitive Orientation Study
April 14, 2022 17:00 ET | Endominance, Inc.
IRVINE, Calif., April 14, 2022 (GLOBE NEWSWIRE) -- Endominance, Inc., a leading cognitive assessment and data collection firm headquartered in Virginia, today announced the launch of a...
Vantage Market Research.png
Global $27+ Million Endoscopy Equipment and Software Market is Expected to Grow at a CAGR of over 6.20% During 2022-2028 | Vantage Market Research
April 05, 2022 05:46 ET | Vantage Market Research
WASHINGTON, April 05, 2022 (GLOBE NEWSWIRE) -- The "Endoscopy Equipment and Software Market Size, Share & Trends Analysis Report by Product (Endoscope, Visualization Systems, Software,...
attralus-logo.png
Positive New Data from Phase 1/2 Trial of AT-01 Presented at 2022 American College of Cardiology Annual Scientific Session
April 04, 2022 08:00 ET | Attralus, Inc
AT-01 is a first-in-class pan-amyloid imaging agent capable of detecting diverse types of amyloidSensitivity in those with previously diagnosed cardiac disease was 100% in ATTR and 93% in ALCardiac...
Featured Image for Medical Database, Inc.
Medical Database, Inc. Integrates Its Laboratory Decision System, LDS®, With Epic
March 23, 2022 10:01 ET | Medical Database, Inc
IRVINE, Calif., March 23, 2022 (GLOBE NEWSWIRE) -- Medical Database, Inc., an innovative provider of clinical laboratory and medical content, today announced the successful integration of its...
Vantage Market Research.png
The Future of Precision medicine software Market Economy Size Expected a Growth of USD 2288.82 Million by 2028 | According to Vantage Market Research
March 16, 2022 08:43 ET | Vantage Market Research
WASHINGTON, March 16, 2022 (GLOBE NEWSWIRE) -- According to a new market research report "Precision medicine software market Size, Share & Trends Analysis Report by Delivery Mode (On-premise...